cilostazol has been researched along with Autism Spectrum Disorder in 2 studies
Autism Spectrum Disorder: Wide continuum of associated cognitive and neurobehavioral disorders, including, but not limited to, three core-defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behaviors. (from DSM-V)
Excerpt | Relevance | Reference |
---|---|---|
"We aimed to evaluate cilostazol therapeutic effects on aberrant behaviors of autism spectrum disorder (ASD) children and its safety profile in a double-blind, randomized clinical trial." | 9.69 | Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial. ( Akhondzadeh, S; Bagheri, S; Ebrahimi, P; Moeini, M; Mohammadi, MR; Moradi, K; Seyedmirzaei, H, 2023) |
"The cilostazol regimen, attenuated prenatal VPA exposure associated hyperlocomotion, social interaction deficits, repetitive behavior, and anxiety." | 8.02 | Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder. ( Kulkarni, GT; Luhach, K; Sharma, B; Singh, VP, 2021) |
"The cilostazol regimen, attenuated prenatal VPA exposure associated hyperlocomotion, social interaction deficits, repetitive behavior, and anxiety." | 4.02 | Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder. ( Kulkarni, GT; Luhach, K; Sharma, B; Singh, VP, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Luhach, K | 1 |
Kulkarni, GT | 1 |
Singh, VP | 1 |
Sharma, B | 1 |
Ebrahimi, P | 1 |
Seyedmirzaei, H | 1 |
Moradi, K | 1 |
Bagheri, S | 1 |
Moeini, M | 1 |
Mohammadi, MR | 1 |
Akhondzadeh, S | 1 |
1 trial available for cilostazol and Autism Spectrum Disorder
Article | Year |
---|---|
Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial.
Topics: Antipsychotic Agents; Autism Spectrum Disorder; Child; Cilostazol; Double-Blind Method; Drug Therapy | 2023 |
1 other study available for cilostazol and Autism Spectrum Disorder
Article | Year |
---|---|
Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder.
Topics: Animals; Anticonvulsants; Anxiety; Autism Spectrum Disorder; Behavior, Animal; Biomarkers; Brain; Ci | 2021 |